Streetbeat News

CANO

Cano Health Inc

https://canohealth.com

CEO

Marlow Hernandez Cano

Employees

2,200

Industry

General Medical and Surgical Hospitals

Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico.

Open

2.39

Mkt cap

12M

Volume

173K

High

2.46

P/E Ratio

-0.01

52-wk high

190.00

Low

2.18

Div yield

N/A

52-wk low

1.74

In Wednesday's intraday session, several healthcare stocks experienced significant movements. NexImmune (NEXI) saw a substantial increase of 230.5%, while ABVC BioPharma (ABVC) and First Wave BioPharma (FWBI) also posted notable gains. Conversely, Nemaura Medical (NMRD), TC BioPharm (TCBP), and Esperion Therapeutics (ESPR) were among the stocks that declined. These movements reflect the volatility and rapid changes in the healthcare sector, impacting the market value of these companies.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 5:31 pm

Cano Health has been notified by the NYSE of non-compliance with market capitalization criteria. The company is expediting its transformation plan and aims to achieve $290 million in cost reductions.

Portfolio Pulse from Bill Haddad

December 29, 2023 | 9:43 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Intensity Therapeutics (INTS) saw a notable increase of 107.2%, while Conduit Pharmaceuticals (CDT) and ALX Oncology Holdings (ALXO) also saw substantial gains. On the other hand, AquaBounty Techs (AQB), Veradigm (MDRX), and Cano Health (CANO) were among the stocks that declined. These movements reflect the dynamic nature of the healthcare sector and may be influenced by company-specific news or broader market trends.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 5:31 pm

AeroVironment, Inc. (NASDAQ:AVAV) shares fell over 9% despite reporting Q2 earnings and revenue that beat estimates. The company's adjusted earnings were 97 cents per share, surpassing the expected 62 cents, with revenue at $180.8 million against the forecasted $170.908 million. Other stocks experienced significant movements in Wednesday's mid-day session, with notable gainers including Sera Prognostics, Inc. (NASDAQ:SERA) and MicroAlgo Inc. (NASDAQ:MLGO), and losers such as NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) and ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA).

Portfolio Pulse from Lisa Levin

December 06, 2023 | 7:43 pm

UBS analyst Andrew Mok has downgraded Cano Health (NYSE:CANO) from Neutral to Sell and significantly reduced the price target from $12 to $3.75.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 3:48 pm

Health care stocks experienced significant movement in Friday's intraday session. INVO Bioscience (INVO) saw a 115.4% increase, while Treace Medical Concepts (TMCI) dropped 44.3%. Earnings reports influenced many of the stock movements, with several companies releasing Q3 results recently.

Portfolio Pulse from Benzinga Insights

November 10, 2023 | 5:31 pm

Cano Health's stock price has declined following the release of their mixed Q3 financial results. The company's performance did not align with market expectations on all fronts, leading to a negative reaction from investors.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 4:31 pm

Cano Health (NYSE:CANO) reported Q3 2023 GAAP EPS of $(91.87), missing the estimate of $(18.50) by 396.59%. This is a 39843.48% decrease from the same period last year. However, the company's quarterly sales of $788.07M beat the estimate of $757.20M by 4.08%, marking an 18.51% increase from last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 10:25 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. TRACON Pharma, Doximity, AVITA Medical, Cano Health, DarioHealth, and Evaxion Biotech saw increases, with TRACON Pharma leading with a 71.3% increase. On the other hand, Treace Medical Concepts, Sensus Healthcare, Biolase, TELA Bio, Syndax Pharmaceuticals, and Quantum-Si experienced decreases, with Treace Medical Concepts leading the decline with a 24.1% decrease. Most of these movements were associated with the release of Q3 earnings reports.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:31 pm

Cano Health (NYSE:CANO) is set to release its latest quarterly earnings report on November 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.20. The company's previous quarter saw a miss in EPS by $0.39, leading to a 73.0% drop in share price. Over the last 52-week period, shares are down 95.08%.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 4:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.